Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review

被引:33
|
作者
Hase, Isano [1 ,2 ]
Morimoto, Kozo [3 ]
Sakagami, Takuro [4 ]
Ishii, Yoshiki [2 ]
van Ingen, Jakko [5 ]
机构
[1] Utsunomiya Hosp, Natl Hosp Org, Dept Resp Med, 2160 Shimo Okamoto, Utsunomiya, Tochigi 3291193, Japan
[2] Dokkyo Med Univ, Dept Pulm Med & Clin Immunol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan
[3] Fukujuji Hosp, Japan AntiTB Assoc, Resp Dis Ctr, 3-1-24 Matsuyama, Kiyose, Tokyo 2040022, Japan
[4] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan
[5] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands
关键词
Anti-interferon-gamma autoantibody; Nontuberculous mycobacterium; Clinical manifestation; Ethnicity; Adult-onset immunodeficiency; ADULT-ONSET IMMUNODEFICIENCY; AVIUM COMPLEX INFECTION; ACQUIRED-IMMUNODEFICIENCY; MENDELIAN SUSCEPTIBILITY; RECURRENT; TOXOPLASMOSIS; RITUXIMAB; DIAGNOSIS;
D O I
10.1016/j.diagmicrobio.2017.05.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nontuberculous mycobacteria (NTM) infections involving anti-interferon-gamma(IFN-gamma)-neutralizing auto antibodies have been described in previously immunocompetent adults. To investigate the factors underlying various disease manifestations, we reviewed 35 articles published between January 2004 and November 2016 and identified 111 NTM patients with anti-IFN-gamma, autoantibodies. Rapidly growing mycobacteria (RGM) accounted for 53% of the isolated species. RGM were predominant among the NTM species isolated from Thai (73%), Chinese (58%) and Filipino (56%) patients, whereas M. avium complex (MAC) was predominant among Japanese (58%) and non-Asian (80%) patients. The commonly involved organs included the lymph nodes (79%), bones/joints (34%) and lungs (32%). Compared with the patients with MAC, the patients with RGM had a higher incidence of lymph node lesions (P < 0.05) and a lower incidence of bone/joint (P < 0.01), lung (P < 0.01), soft tissue (P < 0.01), bronchus (P < 0.01) and muscle (P < 0.05) lesions. Clinical manifestations of NTM disease with anti-IFN-gamma-neutralizing autoantibodies differ across ethnicities and NTM species. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 38 条
  • [11] Mycobacterial lymphadenitis without granuloma formation in a patient with anti-interferon-gamma antibodies
    Asako, Mizuki
    Matsunaga, Hitomi
    Nakahara, Wataru
    Ikeda, Mako
    Mima, Fuka
    Minami, Ryota
    Sekiguchi, Masahiro
    Oka, Kazumasa
    Wada, Naoki
    Suzuki, Katsuhiro
    Yoshizawa, Kazutaka
    Sakagami, Takuro
    Ueda, Shuji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (05) : 630 - 635
  • [12] Anti-interferon-gamma autoantibody related disseminated nontuberculous mycobacteriosis with pathological features of immunoglobulin G4-related disease
    Nagamura, Norihiro
    Imada, Toshihiro
    IMMUNOLOGICAL MEDICINE, 2022, 45 (01) : 48 - 53
  • [13] Neutralizing Anti-Interferon-Gamma Autoantibody Levels May Not Correlate With Clinical Course of Disease
    Tham, Elizabeth Huiwen
    Huang, Chiung-Hui
    Soh, Jian Yi
    Thayalasingam, Meera
    Lee, Alison Joanne
    Lum, Lionel Hon Wei
    Poon, Li Mei
    Lye, David Chien Boon
    Chai, Louis Yi Ann
    Tambyah, Paul Anantharajah
    Lee, Bee Wah
    Shek, Lynette Pei-Chi
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (04) : 572 - +
  • [14] Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection
    Harada, Masanori
    Furuhashi, Kazuki
    Karayama, Masato
    Suzuki, Yuzo
    Hozumi, Hironao
    Enomoto, Noriyuki
    Fujisawa, Tomoyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (02) : 373 - 378
  • [15] Treatment of anti-interferon-gamma autoantibody associated acquired immunodeficiency syndrome with bortezomib: pilot study
    Angkasekwinai, N.
    Pithukpakorn, M.
    Phoompoung, P.
    Tantibhedhyangkul, W.
    Onlamoon, N.
    Suputtamongkol, Y.
    SWISS MEDICAL WEEKLY, 2022, 152 : 4S - 4S
  • [16] Neutralizing Anti-Interferon-Gamma Autoantibody Levels May Not Correlate With Clinical Course of Disease Reply
    Xie, Yingda L.
    Chen, Ray Y.
    Sereti, Irini
    Zerbe, Christa S.
    Holland, Steven M.
    Browne, Sarah K.
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (04) : 573 - 574
  • [17] Disseminated nontuberculous mycobacterial infection in the context of interferon-gamma autoantibody syndrome: A case report and review of the literature
    Jordan, Victoria
    Pickles, Robert
    EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY, 2025,
  • [18] Reactive neutrophilic dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody
    Liao, Nien-Feng Chang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB114 - AB114
  • [19] Skin Manifestations in Patients with Adult-onset Immunodeficiency due to Anti-interferon-gamma Autoantibody: A Relationship with Systemic Infections
    Jutivorakool, Kamonwan
    Sittiwattanawong, Prattana
    Kantikosum, Kornphaka
    Hurst, Cameron P.
    Kumtornrut, Chanat
    Asawanonda, Pravit
    Klaewsongkram, Jettanong
    Rerknimitr, Pawinee
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (08) : 742 - 747
  • [20] A Novel Assay To Detect Neutralizing Anti-Interferon-Gamma Autoantibody In Clinical Samples With Disseminated Non-Tuberculous Mycobacterial Infection
    Shima, K.
    Sakagami, T.
    Aoki, N.
    Moro, H.
    Tanabe, Y.
    Suzuki, E.
    Kuwabara, K.
    Narita, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187